Graham Walmsley's Insider Trades & SAST Disclosures
Graham Walmsley's most recent trade in Akero Therapeutics Inc was a trade of 91,309 Common Stock done at an average price of $44.7 . Disclosure was reported to the exchange on March 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Graham Walmsley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 44.75 per share. | 25 Mar 2025 | 91,309 | 1,091,309 (3%) | 0% | 44.7 | 4,085,804 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 43.01 per share. | 25 Mar 2025 | 58,691 | 1,150,000 (4%) | 0% | 43.0 | 2,524,417 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 43.55 per share. | 25 Mar 2025 | 50,000 | 1,200,000 (4%) | 0% | 43.6 | 2,177,700 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 48.00 per share. | 30 Jan 2025 | 200,000 | 1,000,000 (3%) | 0% | 48 | 9,600,000 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 0 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 1,408,875 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharmaceuticals Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 700,761 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 0 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2024 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2024 | 700,000 | 700,761 | - | 14.9 | 10,395,000 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2024 | 475,000 | 708,114 | - | 14.9 | 7,053,750 | Common Stock |
| Akero Therapeutics Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 19.80 per share. | 08 Dec 2023 | 50,000 | 750,000 (2%) | 0% | 19.8 | 990,240 | Common Stock |
| Akero Therapeutics Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 19.85 per share. | 08 Dec 2023 | 50,000 | 800,000 (2%) | 0% | 19.9 | 992,700 | Common Stock |
| Akero Therapeutics Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 16.99 per share. | 30 Nov 2023 | 50,000 | 700,000 (2%) | 0% | 17.0 | 849,730 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 30 Nov 2023 | 50,000 | 650,000 (2%) | 0% | 16.9 | 844,835 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 12 Sep 2023 | 700,000 | 700,761 | - | 14.9 | 10,395,000 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 9.84 per share. | 12 Sep 2023 | 508,130 | 1,668,130 | - | 9.8 | 4,999,999 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 12 Sep 2023 | 475,000 | 708,114 | - | 14.9 | 7,053,750 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 13.08 per share. | 12 Sep 2023 | 50,000 | 1,800,000 | - | 13.1 | 654,250 | Common Stock |
| Olema Pharmaceuticals Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 14.95 per share. | 12 Sep 2023 | 50,000 | 1,750,000 | - | 14.9 | 747,480 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 14.73 per share. | 12 Sep 2023 | 31,870 | 1,700,000 | - | 14.7 | 469,550 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 42.06 per share. | 08 Aug 2023 | 25,000 | 600,000 (2%) | 0% | 42.1 | 1,051,475 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 42.69 per share. | 28 Jul 2023 | 30,000 | 550,000 (1%) | 0% | 42.7 | 1,280,709 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 43.26 per share. | 28 Jul 2023 | 25,000 | 575,000 (2%) | 0% | 43.3 | 1,081,525 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 19 Sep 2022 | 400,000 | 400,000 (1%) | 1% | 26 | 10,400,000 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 42.00 per share. | 19 Sep 2022 | 120,000 | 520,000 (1%) | 0% | 42 | 5,040,000 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Alx Oncology Holdings Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock option (right to buy) | |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2021 | 23,832 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Alx Oncology Holdings Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 76.00 per share. | 14 Dec 2020 | 20,000 | 995,000 | - | 76 | 1,520,000 | Common Stock |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | 23 Nov 2020 | 1,400,761 | 1,400,761 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | 23 Nov 2020 | 1,400,761 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | 23 Nov 2020 | 1,183,114 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | 23 Nov 2020 | 1,183,114 | 1,183,114 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 23 Nov 2020 | 1,160,000 | 1,160,000 | - | 19 | 22,040,000 | Common Stock |
| Alx Oncology Holdings Inc | Graham Walmsley | Director | 21 Jul 2020 | 2,105,901 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Graham Walmsley | Director | 21 Jul 2020 | 2,105,901 | 2,161,981 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 975,000 | 975,000 | - | 19 | 18,525,000 | Common Stock |
| Alx Oncology Holdings Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 24,009 | 24,009 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Jun 2020 | 339,578 | 1,400,761 | - | - | Series B Convertible Preferred Stock | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges